Search results
The doctor behind the next big thing in cancer treatment
CNN via Yahoo News· 2 days agoDr Catherine Wu’s research has laid the scientific foundation for the development of cancer vaccines...
Merck’s trial of KEYTRUDA regimen fails to meet primary endpoint
Clinical Trials Arena via Yahoo Finance· 2 days agoEarlier this month, Merck reported the final analysis findings from the Phase III KEYNOTE-811 trial...
Merck Study of Keytruda With Chemotherapy in Endometrial Cancer Fails to Meet Endpoint
Morningstar· 3 days agoMerck was hit with a setback in its efforts to expand its blockbuster cancer immunotherapy Keytruda after a late-stage study of its use in combination with ...
Merck's endometrial cancer therapy fails trial
Reuters via Yahoo News· 3 days agoThe drugmaker's Keytruda therapy in combination with chemotherapy was being evaluated in about 1,095 patients with high-risk endometrial cancer after...
Pharma Stock Roundup: PFE DMD Study Patient Death, FDA Panel Meet for LLY's Donanemab
Zacks· 2 days agoAn FDA advisory committee meeting to discuss Eli Lilly’s (LLY...s (MRK Quick QuoteMRK - Free Report) phase III study evaluating a Keytruda-based regimen for an endometrial ...
...Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles...
Fontana Herald News· 2 days agoAethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced ...
Calliditas' survival data salvage midphase cancer trial after primary endpoint miss
FierceBiotech· 5 days agoCalliditas Therapeutics had a typical to-do list for its midphase head and neck cancer study. Step...
Dow Jones Drug Giant Merck, Nvidia Eye Buy Points In Current Stock Market
Investor's Business Daily· 5 days agoMerck stock backstory: On April 25, Merck jumped after the Dow Jones stalwart topped Wall Street's...
Nexavar Dosage: Form, Strength, How to Take, and More
Healthline· 6 days agoNexavar (sorafenib) is a prescription drug used to treat liver, kidney, and thyroid cancers. Nexavar belongs to a group of drugs called kinase inhibitors ...
Combo Therapy May Be Advance Against Liver Cancer
KTBS Shreveport· 6 days agoA new combination therapy appears to boost the response rate for liver cancer patients receiving immunotherapy, according to results from a phase 2...